Form 8-K - Current report:
SEC Accession No. 0001213900-18-010718
Filing Date
2018-08-10
Accepted
2018-08-10 16:33:33
Documents
4
Period of Report
2018-08-10
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k081018_aytubioscience.htm 8-K 17215
2 CERTIFICATE OF AMENDMENT TO THE RESTATED CERTIFICATE OF INCORPORATION OF AYTU BI f8k081018ex3-1_aytubio.htm EX-3.1 12819
3 PRESS RELEASE DATED AUGUST 10, 2018 f8k081018ex99-1_aytubio.htm EX-99.1 8627
4 GRAPHIC ex3-1img001.jpg GRAPHIC 8310
  Complete submission text file 0001213900-18-010718.txt   51674
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 181009286
SIC: 2834 Pharmaceutical Preparations